LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance [Yahoo! Finance]
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement